ARCHIMED completed the acquisition of BioVendor Group.

ARCHIMED, a private equity healthcare specialist, completed the acquisition of BioVendor Group, a global integrated diagnostic player. Financial terms were not disclosed. "Working closely with management, ARCHIMED will deploy its MedValue template – ARCHIMED’s playbook for accelerating the growth of partnering companies – for development via internationalization (often including acquisitions), innovation and product range expansion. ARCHIMED will help materially bolster commercial efforts, as well as BioVendor’s already high-quality control & regulatory compliance capabilities," ARCHIMED statement.